60 Degrees Pharmaceuticals (SCTP) Proxy Filing summary

Executive summary

• The annual meeting will be held virtually on October 8, 2025, with voting available by telephone or mail for shareholders of record as of August 29, 2025.

• Key proposals include director elections, amendments to the equity incentive plan, a reverse stock split, auditor ratification, and potential adjournment to solicit more proxies.

• Proxy materials are primarily distributed electronically to expedite delivery, reduce costs, and conserve resources.

Voting matters and shareholder proposals

• Shareholders will vote on electing five directors, increasing shares under the 2022 Equity Incentive Plan by 250,000, approving a reverse stock split (1:3 to 1:10), ratifying RBSM LLP as auditor, and adjourning the meeting if needed.

• The board recommends voting FOR all proposals.

• Shareholder proposals for the 2026 meeting must be submitted 90–120 days before the anniversary of the prior meeting.

Board of directors and corporate governance

• The board consists of five directors, three of whom are independent under Nasdaq rules.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and responsibilities.

• The board met five times in 2024, with all directors attending all meetings.

• The nominating committee values diversity in experience, gender, race, ethnicity, and age, though there is no formal diversity policy.

• Stockholders can communicate directly with the board via written correspondence.